DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
42
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.8%
Neutral
18.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $9 |
138%
upside
| 1 | +19% |
0
%
| 25 Nov ‘25 8 days ago |
|
|
|
Neutral
Reiterated
| $157 |
13%
downside
| 1 | – |
–
| 21 Nov ‘25 12 days ago |
|
|
|
Overweight
Maintained
| $381 |
10%
upside
| 1 | +5.1% |
0
%
| 14 Nov ‘25 19 days ago |
|
|
|
Overweight
Maintained
| $8 |
30%
upside
| 1 | +0.33% |
0
%
| 7 Nov ‘25 26 days ago |
|
|
|
Neutral
Maintained
| $8 |
19%
upside
| 1 | – |
–
| 7 Nov ‘25 27 days ago |
|
|
|
Overweight
Reiterated
| $289 |
26%
upside
| 1 | +7.7% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Overweight
Reiterated
| $41 |
21%
upside
| 1 | +104% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $13 |
7%
upside
| 1 | +22% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $179 |
18%
upside
| 1 | +4.1% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $45 |
52%
upside
| 1 | -5% |
0
%
| 23 Oct ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| $65 |
45%
upside
| 1 | -6.8% |
0
%
| 9 Oct ‘25 1 month ago |
|